Analysis of the Pharmaceutical Market in Malaysia

Attractiveness and Hurdles for Stakeholders in the Next 5 Years

USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

The growing population base, driven by increased life expectancy and domestic investment, is expected to continuously accelerate GDP in Malaysia. Significant growth of healthcare expenditure is expected in the country to facilitate the improvement of medical access and provide companies with revenue-earning opportunities from 2015. Positive macroeconomic and healthcare market trends are expected to fast-track the pharmaceutical market in Malaysia. The study explores the broad competitive landscape, demand dynamics, and regulatory environment that investors must consider while entering this pharmaceutical market.

Table of Contents

Analysis of the Pharmaceutical Market in MalaysiaExecutive SummaryKey Findings Key Questions this Study will AnswerOverview of the Malaysian Healthcare MarketOverview of the Malaysian Healthcare MarketOverview of the Malaysian Healthcare Market (continued)Overview of the Malaysian Healthcare Market (continued)Overview of the Malaysian Healthcare Market (continued)Overview of the Malaysian Healthcare Market (continued)Overview of the Malaysian Healthcare Market (continued)Overview of the Malaysian Healthcare Market (continued)Overview of Malaysian Public and Private Healthcare SystemsOverview of Malaysian Public and Private Healthcare Systems (continued)Algorithm of Malaysian Healthcare SystemsAlgorithm of Private Healthcare SystemsFuture RoadblocksDemand Dynamics in the Malaysian Healthcare MarketDistribution of Household Income Up to 2012Key Driver in the Malaysian Hospital Market—Growing Admission of Elderly PopulationKey Driver in the Malaysian Private Hospital Segment—Medical TourismKey Drivers in the Malaysian Hospital Market—Chronic and Lifestyle DiseasesOverview of the Malaysian Pharmaceutical MarketOverview of the Malaysian Pharmaceutical MarketRevenue Forecast for the Malaysian Pharmaceutical MarketPharmaceutical Market Components by PercentageMalaysian Pharmaceutical Market—SegmentationMalaysian Pharmaceutical Market—Segmentation (continued)Halal Medicine Market in MalaysiaMalaysian Regulatory LandscapeKey Driver in the Malaysian Pharmaceutical Market—NKEAImpact of GST on Malaysian Pharmaceutical MarketDrivers and Restraints—Malaysian Pharmaceutical MarketDriversRestraintsProfiles of Pharmaceutical Market ParticipantsHome-grown Participants in the Malaysian Pharmaceutical MarketCCM Pharmaceuticals Sdn BhdKotra Pharma (M) Sdn BhdPharmaniaga BerhadYSP Industries (M) Sdn BhdHovid BerhadMNC Participants in the Malaysian Pharmaceutical MarketPfizer MalaysiaMerck Sharp & Dohme (MSD)Eli LillyGlaxoSmithKline (GSK)Johnson & Johnson Sdn BhdAnalysis of the Pharmaceutical Market ParticipantsPESTLE AnalysisPorter Five Forces Analysis for the Malaysian Pharmaceutical MarketThe Future of the Malaysian Pharmaceutical MarketThe Future of the Malaysian Pharmaceutical Market—Key Focus AreasLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Nov-17

Region : North America

Release Date : 15-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.